Alison Kanski

Most Recent Articles by Alison Kanski

Five things for pharma marketers to know: Friday, August 17, 2018

Five things for pharma marketers to know: Friday, August 17, 2018

By

Purdue Pharma taps financial restructuring firm; White House wants opioid-production cut; NYU to make med school free.

First generic version of EpiPen approved by FDA

First generic version of EpiPen approved by FDA

By

Teva's generic EpiPen injector received a thumbs up from the FDA on Thursday.

Study: FDA anti-tobacco campaign prevented 350,000 teens from smoking

Study: FDA anti-tobacco campaign prevented 350,000 teens from smoking

By

The study estimated the FDA's anti-smoking campaign, The Real Cost, saved $31 billion in smoking-related costs to society.

Five things for pharma marketers to know: Wednesday, August 15, 2018

Five things for pharma marketers to know: Wednesday, August 15, 2018

By

Alphabet invests more in Oscar; ViiV's HIV injection proves effective; Gilead's chief medical officer departs in latest executive exit.

Novartis names Klaus Moosmayer ethics, risk, and compliance chief

Novartis names Klaus Moosmayer ethics, risk, and compliance chief

By

Moosmayer is set to join the pharma company in December.

More Articles by Alison Kanski